

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.19324306 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.15799679 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.01156313 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.78788669 |
| 5 | vocalization behavior (GO:0071625) | 5.70682507 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.50754965 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.42262542 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.27150606 |
| 9 | glutamate secretion (GO:0014047) | 5.16114814 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.04908448 |
| 11 | layer formation in cerebral cortex (GO:0021819) | 5.03736066 |
| 12 | protein localization to synapse (GO:0035418) | 5.03074526 |
| 13 | neuron cell-cell adhesion (GO:0007158) | 5.00597312 |
| 14 | central nervous system myelination (GO:0022010) | 4.98839833 |
| 15 | axon ensheathment in central nervous system (GO:0032291) | 4.98839833 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.88471618 |
| 17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.82005411 |
| 18 | exploration behavior (GO:0035640) | 4.80789678 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.79334989 |
| 20 | dendritic spine morphogenesis (GO:0060997) | 4.69024373 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.58885960 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.54409913 |
| 23 | regulation of synapse structural plasticity (GO:0051823) | 4.41945551 |
| 24 | cerebellar granule cell differentiation (GO:0021707) | 4.35367207 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.33539414 |
| 26 | neurotransmitter secretion (GO:0007269) | 4.24529268 |
| 27 | synaptic transmission, glutamatergic (GO:0035249) | 4.21217078 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 4.20886244 |
| 29 | amino acid import (GO:0043090) | 4.19570280 |
| 30 | neuronal action potential propagation (GO:0019227) | 4.11626563 |
| 31 | neuron recognition (GO:0008038) | 4.10920566 |
| 32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.10096849 |
| 33 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.00010699 |
| 34 | gamma-aminobutyric acid transport (GO:0015812) | 3.99613353 |
| 35 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.98272811 |
| 36 | long-term memory (GO:0007616) | 3.94699453 |
| 37 | neuron-neuron synaptic transmission (GO:0007270) | 3.91026666 |
| 38 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.89835939 |
| 39 | positive regulation of membrane potential (GO:0045838) | 3.88890456 |
| 40 | axonal fasciculation (GO:0007413) | 3.84353333 |
| 41 | proline transport (GO:0015824) | 3.82899198 |
| 42 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.78209194 |
| 43 | potassium ion import (GO:0010107) | 3.77363171 |
| 44 | positive regulation of synapse maturation (GO:0090129) | 3.77280946 |
| 45 | dendrite morphogenesis (GO:0048813) | 3.75444124 |
| 46 | potassium ion homeostasis (GO:0055075) | 3.71000362 |
| 47 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.70397375 |
| 48 | transmission of nerve impulse (GO:0019226) | 3.66889099 |
| 49 | postsynaptic membrane organization (GO:0001941) | 3.62824578 |
| 50 | auditory behavior (GO:0031223) | 3.62581459 |
| 51 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.60434247 |
| 52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.59733468 |
| 53 | regulation of synaptic plasticity (GO:0048167) | 3.59056686 |
| 54 | cellular potassium ion homeostasis (GO:0030007) | 3.58452550 |
| 55 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.58020282 |
| 56 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.54545866 |
| 57 | neuromuscular process controlling balance (GO:0050885) | 3.46213531 |
| 58 | neurotransmitter transport (GO:0006836) | 3.45288873 |
| 59 | positive regulation of dendritic spine development (GO:0060999) | 3.39036730 |
| 60 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.38086654 |
| 61 | membrane depolarization during action potential (GO:0086010) | 3.38036223 |
| 62 | synaptic vesicle endocytosis (GO:0048488) | 3.37362557 |
| 63 | activation of protein kinase A activity (GO:0034199) | 3.36889628 |
| 64 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.35698929 |
| 65 | regulation of dendritic spine development (GO:0060998) | 3.34788981 |
| 66 | response to auditory stimulus (GO:0010996) | 3.34564202 |
| 67 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.34173791 |
| 68 | dendritic spine organization (GO:0097061) | 3.33376046 |
| 69 | neurotransmitter uptake (GO:0001504) | 3.33194708 |
| 70 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.32930602 |
| 71 | regulation of neurotransmitter secretion (GO:0046928) | 3.32883121 |
| 72 | presynaptic membrane assembly (GO:0097105) | 3.30560160 |
| 73 | regulation of synapse maturation (GO:0090128) | 3.30202211 |
| 74 | cell migration in hindbrain (GO:0021535) | 3.30149522 |
| 75 | sodium ion export (GO:0071436) | 3.29377224 |
| 76 | long-term synaptic potentiation (GO:0060291) | 3.28927335 |
| 77 | establishment of mitochondrion localization (GO:0051654) | 3.26268095 |
| 78 | acidic amino acid transport (GO:0015800) | 3.26230039 |
| 79 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.24972397 |
| 80 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.24527531 |
| 81 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.23904075 |
| 82 | regulation of vesicle fusion (GO:0031338) | 3.23297823 |
| 83 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.23021833 |
| 84 | neuromuscular synaptic transmission (GO:0007274) | 3.22409307 |
| 85 | neuronal ion channel clustering (GO:0045161) | 3.20126891 |
| 86 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.20020587 |
| 87 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.19504282 |
| 88 | cellular sodium ion homeostasis (GO:0006883) | 3.17740310 |
| 89 | regulation of neurotransmitter levels (GO:0001505) | 3.17692920 |
| 90 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.16481627 |
| 91 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.15648981 |
| 92 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.13671418 |
| 93 | presynaptic membrane organization (GO:0097090) | 3.13516141 |
| 94 | learning (GO:0007612) | 3.13456211 |
| 95 | synapse assembly (GO:0007416) | 3.10663207 |
| 96 | glycine transport (GO:0015816) | 3.10232524 |
| 97 | L-amino acid import (GO:0043092) | 3.08876982 |
| 98 | innervation (GO:0060384) | 3.07431084 |
| 99 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.04175554 |
| 100 | regulation of neurotransmitter transport (GO:0051588) | 3.03949967 |
| 101 | mechanosensory behavior (GO:0007638) | 3.03792348 |
| 102 | synaptic transmission (GO:0007268) | 3.03493221 |
| 103 | membrane depolarization (GO:0051899) | 3.03336167 |
| 104 | prepulse inhibition (GO:0060134) | 3.01243324 |
| 105 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.00276520 |
| 106 | positive regulation of neurotransmitter transport (GO:0051590) | 3.00241198 |
| 107 | cell communication by electrical coupling (GO:0010644) | 2.99125546 |
| 108 | vesicle transport along microtubule (GO:0047496) | 2.98495402 |
| 109 | intraspecies interaction between organisms (GO:0051703) | 2.97503583 |
| 110 | social behavior (GO:0035176) | 2.97503583 |
| 111 | organelle transport along microtubule (GO:0072384) | 2.97211719 |
| 112 | neuromuscular process (GO:0050905) | 2.96371956 |
| 113 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.96356182 |
| 114 | regulation of ARF protein signal transduction (GO:0032012) | 2.96337589 |
| 115 | behavioral defense response (GO:0002209) | 2.95974516 |
| 116 | behavioral fear response (GO:0001662) | 2.95974516 |
| 117 | cell differentiation in hindbrain (GO:0021533) | 2.94947251 |
| 118 | membrane hyperpolarization (GO:0060081) | 2.94636916 |
| 119 | regulation of synaptic transmission (GO:0050804) | 2.94389976 |
| 120 | cerebellar Purkinje cell layer development (GO:0021680) | 2.94261169 |
| 121 | synapse organization (GO:0050808) | 2.91871984 |
| 122 | adult walking behavior (GO:0007628) | 2.91485581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.28308952 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.35982724 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.10802529 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.10221769 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98387019 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.74321443 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.74321443 |
| 8 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.73376007 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.61899294 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.61638711 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.61098511 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.57291781 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.56202148 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53264407 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.53125878 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.52931957 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44948797 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.35173489 |
| 19 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.32776716 |
| 20 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.23589654 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.23349008 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.22756135 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.14232702 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.09595609 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.98885156 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.98309713 |
| 27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.98136336 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.97862352 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.92711177 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.78058823 |
| 31 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.62858839 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59407795 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56129491 |
| 34 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54664159 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52592988 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.49408922 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46816130 |
| 38 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.41628393 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40213663 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36006753 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34428315 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31046230 |
| 43 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30942399 |
| 44 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.30471521 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.27680467 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27569697 |
| 47 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26869880 |
| 48 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.24974103 |
| 49 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.22601604 |
| 50 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22129405 |
| 51 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20630940 |
| 52 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20556316 |
| 53 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20142756 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19692300 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19326614 |
| 56 | AR_19668381_ChIP-Seq_PC3_Human | 1.18352325 |
| 57 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18087525 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17642511 |
| 59 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16827912 |
| 60 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.15673906 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15518921 |
| 62 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15117022 |
| 63 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.14554488 |
| 64 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13887568 |
| 65 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.11952546 |
| 66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10127973 |
| 67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.09064297 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07001553 |
| 69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05270579 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05140021 |
| 71 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04700279 |
| 72 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04591883 |
| 73 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03754800 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03230031 |
| 75 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01700855 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01644700 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01250699 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00242010 |
| 79 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.99407397 |
| 80 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.99185544 |
| 81 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98715319 |
| 82 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97716779 |
| 83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97468234 |
| 84 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94760572 |
| 85 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94448793 |
| 86 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94260179 |
| 87 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93692721 |
| 88 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93343184 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93029980 |
| 90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92890028 |
| 91 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92302816 |
| 92 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91186170 |
| 93 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91048491 |
| 94 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90592251 |
| 95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90592251 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90052429 |
| 97 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89044452 |
| 98 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88906381 |
| 99 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87559451 |
| 100 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87467138 |
| 101 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.87211662 |
| 102 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86216764 |
| 103 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.86133226 |
| 104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85657595 |
| 105 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85071666 |
| 106 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85000948 |
| 107 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.84920955 |
| 108 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84800960 |
| 109 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.83288567 |
| 110 | JUN_21703547_ChIP-Seq_K562_Human | 0.83218146 |
| 111 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.82833421 |
| 112 | KDM2B_26808549_Chip-Seq_REH_Human | 0.80905104 |
| 113 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.79808762 |
| 114 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.79756314 |
| 115 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.78241734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.02277463 |
| 2 | MP0003880_abnormal_central_pattern | 4.82670486 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.21673881 |
| 4 | MP0004270_analgesia | 4.06787105 |
| 5 | * MP0002063_abnormal_learning/memory/cond | 3.42247404 |
| 6 | MP0009745_abnormal_behavioral_response | 3.34795479 |
| 7 | MP0005423_abnormal_somatic_nervous | 3.29177587 |
| 8 | MP0002064_seizures | 3.09985852 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.78334332 |
| 10 | MP0009046_muscle_twitch | 2.75423549 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.74715835 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.72141594 |
| 13 | MP0001486_abnormal_startle_reflex | 2.69242247 |
| 14 | MP0002822_catalepsy | 2.51008049 |
| 15 | MP0002272_abnormal_nervous_system | 2.46485668 |
| 16 | MP0000778_abnormal_nervous_system | 2.29100691 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.16445122 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.15688719 |
| 19 | MP0003329_amyloid_beta_deposits | 2.13005602 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.10250995 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.07448046 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.04376274 |
| 23 | MP0002736_abnormal_nociception_after | 2.02176565 |
| 24 | MP0001970_abnormal_pain_threshold | 1.92564642 |
| 25 | MP0004811_abnormal_neuron_physiology | 1.89846736 |
| 26 | MP0002184_abnormal_innervation | 1.85794909 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.84972813 |
| 28 | MP0008569_lethality_at_weaning | 1.84669086 |
| 29 | MP0004885_abnormal_endolymph | 1.79604100 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.79579681 |
| 31 | MP0004858_abnormal_nervous_system | 1.78247653 |
| 32 | MP0004924_abnormal_behavior | 1.72830536 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.72830536 |
| 34 | MP0000955_abnormal_spinal_cord | 1.69594437 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.58252295 |
| 36 | MP0002882_abnormal_neuron_morphology | 1.53886723 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.48511258 |
| 38 | MP0002066_abnormal_motor_capabilities/c | 1.46413386 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.45933966 |
| 40 | MP0003879_abnormal_hair_cell | 1.42124259 |
| 41 | MP0001905_abnormal_dopamine_level | 1.33599147 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.33501599 |
| 43 | MP0001984_abnormal_olfaction | 1.31771831 |
| 44 | MP0003633_abnormal_nervous_system | 1.31190347 |
| 45 | MP0003123_paternal_imprinting | 1.29358532 |
| 46 | MP0001529_abnormal_vocalization | 1.29244822 |
| 47 | MP0003787_abnormal_imprinting | 1.28066297 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.25290248 |
| 49 | MP0002152_abnormal_brain_morphology | 1.24590599 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.18999052 |
| 51 | MP0004142_abnormal_muscle_tone | 1.16502871 |
| 52 | MP0003631_nervous_system_phenotype | 1.16433431 |
| 53 | MP0000920_abnormal_myelination | 1.15683634 |
| 54 | MP0004742_abnormal_vestibular_system | 1.04797301 |
| 55 | MP0003634_abnormal_glial_cell | 1.03105524 |
| 56 | MP0002229_neurodegeneration | 1.01660847 |
| 57 | MP0003690_abnormal_glial_cell | 1.01652053 |
| 58 | MP0001177_atelectasis | 0.99282952 |
| 59 | MP0005551_abnormal_eye_electrophysiolog | 0.98423515 |
| 60 | MP0001188_hyperpigmentation | 0.97600568 |
| 61 | MP0008877_abnormal_DNA_methylation | 0.97463026 |
| 62 | MP0000604_amyloidosis | 0.95847313 |
| 63 | MP0002069_abnormal_eating/drinking_beha | 0.95292032 |
| 64 | MP0003121_genomic_imprinting | 0.94995326 |
| 65 | MP0003632_abnormal_nervous_system | 0.92396703 |
| 66 | MP0000751_myopathy | 0.86767776 |
| 67 | MP0005409_darkened_coat_color | 0.85542012 |
| 68 | MP0000631_abnormal_neuroendocrine_gland | 0.84776594 |
| 69 | MP0001963_abnormal_hearing_physiology | 0.83947492 |
| 70 | MP0004147_increased_porphyrin_level | 0.83663616 |
| 71 | MP0003122_maternal_imprinting | 0.83551887 |
| 72 | MP0003075_altered_response_to | 0.83163342 |
| 73 | MP0002752_abnormal_somatic_nervous | 0.83132018 |
| 74 | MP0005394_taste/olfaction_phenotype | 0.82267167 |
| 75 | MP0005499_abnormal_olfactory_system | 0.82267167 |
| 76 | MP0003283_abnormal_digestive_organ | 0.82220910 |
| 77 | MP0008874_decreased_physiological_sensi | 0.80993822 |
| 78 | MP0008872_abnormal_physiological_respon | 0.80045450 |
| 79 | MP0010386_abnormal_urinary_bladder | 0.79564033 |
| 80 | MP0002653_abnormal_ependyma_morphology | 0.79519018 |
| 81 | MP0008961_abnormal_basal_metabolism | 0.78504806 |
| 82 | MP0004085_abnormal_heartbeat | 0.77667324 |
| 83 | MP0002090_abnormal_vision | 0.76441730 |
| 84 | MP0003861_abnormal_nervous_system | 0.75631650 |
| 85 | MP0004145_abnormal_muscle_electrophysio | 0.75166225 |
| 86 | MP0000026_abnormal_inner_ear | 0.74755676 |
| 87 | MP0005535_abnormal_body_temperature | 0.73052060 |
| 88 | MP0001346_abnormal_lacrimal_gland | 0.72669624 |
| 89 | MP0001986_abnormal_taste_sensitivity | 0.72307081 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.69619814 |
| 91 | MP0003137_abnormal_impulse_conducting | 0.68705415 |
| 92 | MP0005623_abnormal_meninges_morphology | 0.66986454 |
| 93 | MP0001299_abnormal_eye_distance/ | 0.65369987 |
| 94 | MP0004130_abnormal_muscle_cell | 0.65355539 |
| 95 | MP0005187_abnormal_penis_morphology | 0.64410520 |
| 96 | MP0003938_abnormal_ear_development | 0.64178981 |
| 97 | MP0006292_abnormal_olfactory_placode | 0.62279076 |
| 98 | MP0003172_abnormal_lysosome_physiology | 0.60511182 |
| 99 | MP0001664_abnormal_digestion | 0.58405172 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.58333369 |
| 101 | MP0001348_abnormal_lacrimal_gland | 0.58229140 |
| 102 | MP0004510_myositis | 0.57618571 |
| 103 | MP0000579_abnormal_nail_morphology | 0.56795671 |
| 104 | MP0010769_abnormal_survival | 0.56619448 |
| 105 | MP0002638_abnormal_pupillary_reflex | 0.56098818 |
| 106 | MP0001943_abnormal_respiration | 0.55564026 |
| 107 | MP0010768_mortality/aging | 0.55513243 |
| 108 | MP0004233_abnormal_muscle_weight | 0.55425563 |
| 109 | MP0002234_abnormal_pharynx_morphology | 0.54576834 |
| 110 | MP0002082_postnatal_lethality | 0.54387571 |
| 111 | MP0010770_preweaning_lethality | 0.54387571 |
| 112 | MP0004484_altered_response_of | 0.53873749 |
| 113 | MP0003136_yellow_coat_color | 0.53776880 |
| 114 | MP0004215_abnormal_myocardial_fiber | 0.53667672 |
| 115 | MP0004133_heterotaxia | 0.52116078 |
| 116 | MP0000566_synostosis | 0.51134919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.99594274 |
| 2 | Myokymia (HP:0002411) | 6.91586253 |
| 3 | Focal seizures (HP:0007359) | 5.39976691 |
| 4 | Visual hallucinations (HP:0002367) | 4.97891753 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.72814799 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 4.34213541 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 3.95900586 |
| 8 | Ankle clonus (HP:0011448) | 3.93581266 |
| 9 | Atonic seizures (HP:0010819) | 3.77015196 |
| 10 | Mutism (HP:0002300) | 3.76042479 |
| 11 | Febrile seizures (HP:0002373) | 3.71384789 |
| 12 | Broad-based gait (HP:0002136) | 3.70031744 |
| 13 | Neurofibrillary tangles (HP:0002185) | 3.66626584 |
| 14 | Absence seizures (HP:0002121) | 3.65343553 |
| 15 | Papilledema (HP:0001085) | 3.58311195 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.56096815 |
| 17 | Action tremor (HP:0002345) | 3.54364925 |
| 18 | Poor eye contact (HP:0000817) | 3.53250010 |
| 19 | Cerebral inclusion bodies (HP:0100314) | 3.42180705 |
| 20 | Dialeptic seizures (HP:0011146) | 3.38016946 |
| 21 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.36270036 |
| 22 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.29181244 |
| 23 | Impaired social interactions (HP:0000735) | 3.18188571 |
| 24 | Abnormal social behavior (HP:0012433) | 3.18188571 |
| 25 | Abnormality of the corticospinal tract (HP:0002492) | 3.15789222 |
| 26 | Dysmetria (HP:0001310) | 3.12314362 |
| 27 | Hyperventilation (HP:0002883) | 3.11281281 |
| 28 | Depression (HP:0000716) | 3.10474862 |
| 29 | Drooling (HP:0002307) | 3.05034199 |
| 30 | Excessive salivation (HP:0003781) | 3.05034199 |
| 31 | Dysdiadochokinesis (HP:0002075) | 3.00904010 |
| 32 | Urinary urgency (HP:0000012) | 2.99830574 |
| 33 | Spastic gait (HP:0002064) | 2.98746141 |
| 34 | Gaze-evoked nystagmus (HP:0000640) | 2.95638473 |
| 35 | Postural instability (HP:0002172) | 2.91955714 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.87368128 |
| 37 | Megalencephaly (HP:0001355) | 2.85322623 |
| 38 | Amblyopia (HP:0000646) | 2.85290015 |
| 39 | Hemiparesis (HP:0001269) | 2.84914525 |
| 40 | Anxiety (HP:0000739) | 2.83208913 |
| 41 | Truncal ataxia (HP:0002078) | 2.80529782 |
| 42 | Termporal pattern (HP:0011008) | 2.76698391 |
| 43 | Insidious onset (HP:0003587) | 2.76698391 |
| 44 | Genetic anticipation (HP:0003743) | 2.76027062 |
| 45 | Torticollis (HP:0000473) | 2.74965932 |
| 46 | Intention tremor (HP:0002080) | 2.74608194 |
| 47 | Cerebral hypomyelination (HP:0006808) | 2.71913905 |
| 48 | Progressive inability to walk (HP:0002505) | 2.71307894 |
| 49 | Abnormality of binocular vision (HP:0011514) | 2.68739674 |
| 50 | Diplopia (HP:0000651) | 2.68739674 |
| 51 | Amyotrophic lateral sclerosis (HP:0007354) | 2.63642100 |
| 52 | Abnormality of the lower motor neuron (HP:0002366) | 2.57778706 |
| 53 | Tetraplegia (HP:0002445) | 2.57485118 |
| 54 | Focal dystonia (HP:0004373) | 2.52795254 |
| 55 | Limb dystonia (HP:0002451) | 2.52477323 |
| 56 | Stereotypic behavior (HP:0000733) | 2.51841622 |
| 57 | Epileptiform EEG discharges (HP:0011182) | 2.50003129 |
| 58 | Lower limb muscle weakness (HP:0007340) | 2.48328028 |
| 59 | EEG with generalized epileptiform discharges (HP:0011198) | 2.43372853 |
| 60 | Absent speech (HP:0001344) | 2.41521762 |
| 61 | Obstructive sleep apnea (HP:0002870) | 2.40673684 |
| 62 | Impaired smooth pursuit (HP:0007772) | 2.37995025 |
| 63 | Scanning speech (HP:0002168) | 2.37885765 |
| 64 | Bradykinesia (HP:0002067) | 2.37366723 |
| 65 | Hypsarrhythmia (HP:0002521) | 2.34038148 |
| 66 | Spastic tetraparesis (HP:0001285) | 2.32653757 |
| 67 | Polyphagia (HP:0002591) | 2.30528435 |
| 68 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.28359772 |
| 69 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.28359772 |
| 70 | Akinesia (HP:0002304) | 2.28267722 |
| 71 | Insomnia (HP:0100785) | 2.27010897 |
| 72 | Hemiplegia (HP:0002301) | 2.25372112 |
| 73 | Inappropriate behavior (HP:0000719) | 2.25335390 |
| 74 | Craniofacial dystonia (HP:0012179) | 2.24674726 |
| 75 | Generalized myoclonic seizures (HP:0002123) | 2.23399648 |
| 76 | Apathy (HP:0000741) | 2.19209784 |
| 77 | Split foot (HP:0001839) | 2.17230619 |
| 78 | Impaired vibratory sensation (HP:0002495) | 2.16437964 |
| 79 | Inability to walk (HP:0002540) | 2.14874857 |
| 80 | Fetal akinesia sequence (HP:0001989) | 2.14784274 |
| 81 | Clonus (HP:0002169) | 2.10150881 |
| 82 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.08406839 |
| 83 | Agitation (HP:0000713) | 2.07361217 |
| 84 | Increased circulating renin level (HP:0000848) | 2.06991822 |
| 85 | Neuronal loss in central nervous system (HP:0002529) | 2.04077797 |
| 86 | Abnormality of salivation (HP:0100755) | 2.03878204 |
| 87 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.99731038 |
| 88 | Aplasia of the phalanges of the hand (HP:0009802) | 1.99731038 |
| 89 | Aplasia involving bones of the extremities (HP:0009825) | 1.99731038 |
| 90 | Pointed chin (HP:0000307) | 1.98881786 |
| 91 | Lower limb amyotrophy (HP:0007210) | 1.95190067 |
| 92 | Status epilepticus (HP:0002133) | 1.94155678 |
| 93 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.92527459 |
| 94 | Ventricular fibrillation (HP:0001663) | 1.90254469 |
| 95 | Bronchomalacia (HP:0002780) | 1.89715732 |
| 96 | Diminished motivation (HP:0000745) | 1.88620521 |
| 97 | Hypoplasia of the brainstem (HP:0002365) | 1.86601469 |
| 98 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.86601469 |
| 99 | Aqueductal stenosis (HP:0002410) | 1.85215711 |
| 100 | Pheochromocytoma (HP:0002666) | 1.83842715 |
| 101 | Choreoathetosis (HP:0001266) | 1.83824246 |
| 102 | Gait ataxia (HP:0002066) | 1.83011243 |
| 103 | Blue irides (HP:0000635) | 1.82607452 |
| 104 | Delusions (HP:0000746) | 1.82567514 |
| 105 | Annular pancreas (HP:0001734) | 1.82004124 |
| 106 | Incomplete penetrance (HP:0003829) | 1.80563555 |
| 107 | CNS hypomyelination (HP:0003429) | 1.78947003 |
| 108 | Sleep apnea (HP:0010535) | 1.78418027 |
| 109 | Peripheral hypomyelination (HP:0007182) | 1.78306424 |
| 110 | Rapidly progressive (HP:0003678) | 1.78264701 |
| 111 | Hypoplasia of the corpus callosum (HP:0002079) | 1.76498809 |
| 112 | Turricephaly (HP:0000262) | 1.76117815 |
| 113 | Rigidity (HP:0002063) | 1.74225885 |
| 114 | Spastic tetraplegia (HP:0002510) | 1.68601413 |
| 115 | Thickened helices (HP:0000391) | 1.68128237 |
| 116 | Lower limb asymmetry (HP:0100559) | 1.67311687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.78480376 |
| 2 | EPHA4 | 4.16299097 |
| 3 | MAP3K9 | 4.00826353 |
| 4 | NTRK3 | 3.92685772 |
| 5 | MAP3K4 | 2.76820689 |
| 6 | MINK1 | 2.71175261 |
| 7 | PAK6 | 2.49872811 |
| 8 | DAPK2 | 2.44358034 |
| 9 | NTRK2 | 2.35648460 |
| 10 | MAP2K7 | 2.24683177 |
| 11 | PRKD3 | 2.12192736 |
| 12 | KSR2 | 1.93455770 |
| 13 | NTRK1 | 1.79935478 |
| 14 | SIK2 | 1.70399242 |
| 15 | CAMKK1 | 1.70308898 |
| 16 | KSR1 | 1.70042345 |
| 17 | CDK5 | 1.65560055 |
| 18 | MAP2K4 | 1.59446365 |
| 19 | TNIK | 1.56637877 |
| 20 | MAPK13 | 1.55627991 |
| 21 | CASK | 1.53488521 |
| 22 | TYRO3 | 1.45227202 |
| 23 | PHKG1 | 1.44388747 |
| 24 | PHKG2 | 1.44388747 |
| 25 | PNCK | 1.42112490 |
| 26 | RIPK4 | 1.38063158 |
| 27 | DAPK1 | 1.35169785 |
| 28 | CDK19 | 1.34997279 |
| 29 | PRPF4B | 1.33573941 |
| 30 | UHMK1 | 1.31168031 |
| 31 | PLK2 | 1.28427434 |
| 32 | MAP3K12 | 1.19841583 |
| 33 | GRK5 | 1.17127001 |
| 34 | RIPK1 | 1.13530542 |
| 35 | PRKCG | 1.11541146 |
| 36 | STK38 | 1.11319349 |
| 37 | LATS2 | 1.10273635 |
| 38 | FES | 1.07803566 |
| 39 | MAP3K2 | 0.98714819 |
| 40 | CDK18 | 0.98316591 |
| 41 | ARAF | 0.97781500 |
| 42 | CSNK1G2 | 0.97632073 |
| 43 | CDK15 | 0.97576459 |
| 44 | STK11 | 0.94882983 |
| 45 | MARK2 | 0.93885479 |
| 46 | OXSR1 | 0.93862998 |
| 47 | CDK14 | 0.93255169 |
| 48 | TAOK1 | 0.92087588 |
| 49 | CAMK2A | 0.91731206 |
| 50 | PAK3 | 0.88328698 |
| 51 | CAMK1 | 0.86107762 |
| 52 | CDK11A | 0.85735390 |
| 53 | DYRK1A | 0.82555194 |
| 54 | RET | 0.81511598 |
| 55 | CAMK2B | 0.79945903 |
| 56 | PRKCH | 0.79784076 |
| 57 | ALK | 0.79688673 |
| 58 | SGK494 | 0.75636345 |
| 59 | SGK223 | 0.75636345 |
| 60 | MAP3K13 | 0.75527835 |
| 61 | RAF1 | 0.75362988 |
| 62 | PKN1 | 0.74126495 |
| 63 | TNK2 | 0.72926746 |
| 64 | DYRK2 | 0.71860399 |
| 65 | FGFR2 | 0.70106077 |
| 66 | CAMK4 | 0.70079009 |
| 67 | BRSK1 | 0.68564223 |
| 68 | PRKCZ | 0.63489907 |
| 69 | SGK1 | 0.62728793 |
| 70 | CAMK1G | 0.61576012 |
| 71 | FRK | 0.57984848 |
| 72 | PDK1 | 0.57383964 |
| 73 | FYN | 0.56977575 |
| 74 | PTK2B | 0.56810100 |
| 75 | CAMK1D | 0.56636189 |
| 76 | PINK1 | 0.54534722 |
| 77 | PDPK1 | 0.53903573 |
| 78 | FGR | 0.52722868 |
| 79 | STK39 | 0.52280380 |
| 80 | NEK6 | 0.52138495 |
| 81 | ERBB2 | 0.51839076 |
| 82 | CAMKK2 | 0.51776906 |
| 83 | ICK | 0.50179857 |
| 84 | PRKCE | 0.49748568 |
| 85 | MAP3K6 | 0.48055473 |
| 86 | BMPR2 | 0.48047532 |
| 87 | ERBB3 | 0.47306009 |
| 88 | RPS6KA3 | 0.47230416 |
| 89 | LMTK2 | 0.46724459 |
| 90 | BCR | 0.45574652 |
| 91 | CSNK1G3 | 0.44609981 |
| 92 | MAPK10 | 0.43943566 |
| 93 | DMPK | 0.43785961 |
| 94 | WNK1 | 0.43289301 |
| 95 | CSNK1A1L | 0.43238878 |
| 96 | MAP3K7 | 0.42361687 |
| 97 | CDC42BPA | 0.41264053 |
| 98 | MAPK12 | 0.39518571 |
| 99 | SGK3 | 0.38826436 |
| 100 | CAMK2D | 0.37826228 |
| 101 | ROCK2 | 0.37269658 |
| 102 | WNK3 | 0.36972969 |
| 103 | SGK2 | 0.35895242 |
| 104 | ROCK1 | 0.35594893 |
| 105 | NME1 | 0.35323468 |
| 106 | CSNK1D | 0.34842367 |
| 107 | RPS6KA2 | 0.34797769 |
| 108 | CAMK2G | 0.34536007 |
| 109 | DAPK3 | 0.34450957 |
| 110 | MAP3K1 | 0.34347627 |
| 111 | PRKG1 | 0.33679073 |
| 112 | BRAF | 0.33285026 |
| 113 | PRKCA | 0.32124118 |
| 114 | MAPK8 | 0.31202926 |
| 115 | GSK3B | 0.29077599 |
| 116 | PRKCB | 0.28658850 |
| 117 | PRKACA | 0.27251806 |
| 118 | RPS6KB1 | 0.27071838 |
| 119 | CSNK1E | 0.26332666 |
| 120 | CSNK1A1 | 0.24606246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.55250224 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.06087040 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.71618286 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.69718408 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.65929671 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.64929824 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.60203805 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.57059779 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.47002106 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.34297529 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.20279280 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19412398 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.12729575 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.97087799 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.92233116 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.88137230 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.80612415 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.71986569 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69899729 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66578857 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.66113974 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63990188 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.62745719 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.55507967 |
| 25 | Axon guidance_Homo sapiens_hsa04360 | 1.53041779 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.47813614 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.45285577 |
| 28 | Gap junction_Homo sapiens_hsa04540 | 1.44338012 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43068918 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37748540 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33121581 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31235208 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26644553 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.23442994 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19322364 |
| 36 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.18367351 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17856976 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16186515 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13932481 |
| 40 | Melanogenesis_Homo sapiens_hsa04916 | 1.10483736 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05826076 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04816773 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01357876 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 0.96249354 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95114827 |
| 46 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94602772 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.93747438 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90470736 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86961187 |
| 50 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86416426 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86081154 |
| 52 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83757911 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81778405 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80908001 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79864002 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76523884 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75797420 |
| 58 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73813469 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71782246 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71635847 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69809295 |
| 62 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69736550 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69607867 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69415203 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68771955 |
| 66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65913853 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65209668 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64734958 |
| 69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62430982 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.60187669 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58840378 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57016640 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56336107 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55855043 |
| 75 | Alcoholism_Homo sapiens_hsa05034 | 0.54245648 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53619526 |
| 77 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53195256 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52487715 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50515543 |
| 80 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48831235 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.47228864 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46769291 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46759265 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.46125348 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45798818 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44873223 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44731401 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42676662 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42618230 |
| 90 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41751383 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41541654 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41518793 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40872516 |
| 94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.40730050 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40105749 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39543641 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38603284 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37845530 |
| 99 | * Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37685752 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34884866 |
| 101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33791416 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32773606 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31070685 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.30526896 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30506721 |
| 106 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.29734719 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29547566 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28913620 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.27770821 |
| 110 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.24248052 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23129603 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.22049322 |

